Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol (original) (raw)

Abstract

In the presence of phosphatidylserine, [20-3H]-phorbol 12,13-dibutyrate [( 3H]PBt2) bound specifically to a single class of binding sites in mouse brain cytosol (supernatant at 100,000 X g). The dissociation constant for binding was 3.1 X 10(-9) M, and at saturation 23.2 pmol of [3H]PBt2 was bound per mg of cytosolic protein. Less than 1 pmol of [3H]PBt2 per mg bound in the absence of phospholipids. Phosphatidic acid, sphingomyelin, and phosphatidylinositol also were able to reconstitute binding activity, whereas phosphatidylcholine and phosphatidylethanolamine were relatively ineffective. [3H]PBt2 binding was inhibited by phorbol 12-myristate 13-acetate (Ki = 4.4 X 10(-11) M), phorbol 12,13-didecanoate (Ki = 7.7 X 10(-9) M), phorbol 12,13-diacetate (Ki = 4.4 X 10(-7) M) and 4-O-methylphorbol 12-myristate 13-acetate (Ki = 5.1 X 10(-7) M). The apparent Ki values of the phorbol-related diterpenes for inhibiting binding agreed reasonably closely with the values previously determined for mouse brain membrane binding. The biologically inactive derivatives phorbol (30 microM) and 4 alpha-phorbol 12,13-didecanoate (30 microM) did not inhibit binding. The aporeceptor was eluted in one peak during Ultrogel 44 column chromatography, corresponding to a molecular weight of approximately equal to 77,000. Calcium phospholipid-dependent protein kinase C activity was eluted with a profile similar to that of the cytosolic aporeceptor-binding activity.

4208

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blumberg P. M. In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: part 1. Crit Rev Toxicol. 1980 Dec;8(2):153–197. doi: 10.3109/10408448009037493. [DOI] [PubMed] [Google Scholar]
  2. Boutwell R. K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol. 1974 Jan;2(4):419–443. doi: 10.3109/10408447309025704. [DOI] [PubMed] [Google Scholar]
  3. Castagna M., Takai Y., Kaibuchi K., Sano K., Kikkawa U., Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem. 1982 Jul 10;257(13):7847–7851. [PubMed] [Google Scholar]
  4. Delclos K. B., Blumberg P. M. Identification of ascorbic acid as the heat-stable factor from brain which inactivates the phorbol ester receptor. Cancer Res. 1982 Apr;42(4):1227–1232. [PubMed] [Google Scholar]
  5. Delclos K. B., Nagle D. S., Blumberg P. M. Specific binding of phorbol ester tumor promoters to mouse skin. Cell. 1980 Apr;19(4):1025–1032. doi: 10.1016/0092-8674(80)90093-8. [DOI] [PubMed] [Google Scholar]
  6. Delclos K. B., Yeh E., Blumberg P. M. Specific labeling of mouse brain membrane phospholipids with [20-3H]phorbol 12-p-azidobenzoate 13-benzoate, a photolabile phorbol ester. Proc Natl Acad Sci U S A. 1983 May;80(10):3054–3058. doi: 10.1073/pnas.80.10.3054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Diamond L., O'Brien T. G., Baird W. M. Tumor promoters and the mechanism of tumor promotion. Adv Cancer Res. 1980;32:1–74. doi: 10.1016/s0065-230x(08)60360-7. [DOI] [PubMed] [Google Scholar]
  8. Driedger P. E., Blumberg P. M. Specific binding of phorbol ester tumor promoters. Proc Natl Acad Sci U S A. 1980 Jan;77(1):567–571. doi: 10.1073/pnas.77.1.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dunphy W. G., Delclos K. B., Blumberg P. M. Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain. Cancer Res. 1980 Oct;40(10):3635–3641. [PubMed] [Google Scholar]
  10. Dunphy W. G., Kochenburger R. J., Castagna M., Blumberg P. M. Kinetics and subcellular localization of specific [3H]phorbol 12, 13-dibutyrate binding by mouse brain. Cancer Res. 1981 Jul;41(7):2640–2647. [PubMed] [Google Scholar]
  11. Estensen R. D., DeHoogh D. K., Cole C. F. Binding of [3H]12-O-tetradecanoylphorbol-13-acetate to intact human peripheral blood lymphocytes. Cancer Res. 1980 Apr;40(4):1119–1124. [PubMed] [Google Scholar]
  12. Hecker E., Schmidt R. Phorbolesters--the irritants and cocarcinogens of Croton Tiglium L. Fortschr Chem Org Naturst. 1974;31(0):377–467. doi: 10.1007/978-3-7091-7094-6_7. [DOI] [PubMed] [Google Scholar]
  13. Horowitz A. D., Greenebaum E., Weinstein I. B. Identification of receptors for phorbol ester tumor promoters in intact mammalian cells and of an inhibitor of receptor binding in biologic fluids. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2315–2319. doi: 10.1073/pnas.78.4.2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Huberman E., Callaham M. F. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc Natl Acad Sci U S A. 1979 Mar;76(3):1293–1297. doi: 10.1073/pnas.76.3.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Inoue M., Kishimoto A., Takai Y., Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. II. Proenzyme and its activation by calcium-dependent protease from rat brain. J Biol Chem. 1977 Nov 10;252(21):7610–7616. [PubMed] [Google Scholar]
  16. Kinsella A. R., Radman M. Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6149–6153. doi: 10.1073/pnas.75.12.6149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lew K. K., Chritton S., Blumberg P. M. Biological responsiveness to the phorbol esters and specific binding of [3H]phorbol 12,13-dibutyrate in the nematode Caenorhabditis elegans, a manipulable genetic system. Teratog Carcinog Mutagen. 1982;2(1):19–30. doi: 10.1002/1520-6866(1990)2:1<19::aid-tcm1770020104>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  18. Perrella F. W., Ashendel C. L., Boutwell R. K. Specific high-affinity binding of the phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetate to isolated nuclei and nuclear macromolecules in mouse epidermis. Cancer Res. 1982 Sep;42(9):3496–3501. [PubMed] [Google Scholar]
  19. Sando J. J., Hilfiker M. L., Salomon D. S., Farrar J. J. Specific receptors for phorbol esters in lymphoid cell populations: role in enhanced production of T-cell growth factor. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1189–1193. doi: 10.1073/pnas.78.2.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Shoyab M., Todaro G. J. Specific high affinity cell membrane receptors for biologically active phorbol and ingenol esters. Nature. 1980 Dec 4;288(5790):451–455. doi: 10.1038/288451a0. [DOI] [PubMed] [Google Scholar]
  21. Solanki V., Slaga T. J. Specific binding of phorbol ester tumor promoters to intact primary epidermal cells from Sencar mice. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2549–2553. doi: 10.1073/pnas.78.4.2549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Takai Y., Kishimoto A., Iwasa Y., Kawahara Y., Mori T., Nishizuka Y. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem. 1979 May 25;254(10):3692–3695. [PubMed] [Google Scholar]
  23. Yamamoto N., zur Hausen H. Tumour promoter TPA enhances transformation of human leukocytes by Epstein-Barr virus. Nature. 1979 Jul 19;280(5719):244–245. doi: 10.1038/280244a0. [DOI] [PubMed] [Google Scholar]